UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is belching increasing after bariatric bypass surgery in the long term period?

Acta gastro-enterologica belgica, 2021-10, Vol.84 (4), p.601-605

2021

Volltextzugriff (PDF)

Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study

Clinical microbiology and infection, 2015-11, Vol.21 (11), p.1020-1026

2015

Volltextzugriff (PDF)

Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma

Experimental oncology, 2023-05, Vol.42 (3), p.208-214

2023

Volltextzugriff (PDF)

P1182 What has changed in Inflammatory Bowel Disease during last three decades?

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i2108-i2108

2024

Volltextzugriff (PDF)

P316 Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i456-i457

2023

Volltextzugriff (PDF)

P729 Evaluation of hepatobiliary pathologies using transient elastography in patients with inflammatory bowel disease: What about the effect of drugs?

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i858-i860

2023

Volltextzugriff (PDF)

P343 Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S329-S330

2020

Volltextzugriff (PDF)

What is the effect of subepithelial lesions of the esophagus on esophageal motility?

European review for medical and pharmacological sciences, 2022-09, Vol.26 (17), p.6300

2022

Volltextzugriff (PDF)

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

European review for medical and pharmacological sciences, 2016-03, Vol.20 (5), p.858

2016

Volltextzugriff (PDF)

Mesoatrial shunt in Budd-Chiari syndrome

The American journal of surgery, 2000-04, Vol.179 (4), p.304-308

2000

Volltextzugriff (PDF)

Comparison of Prognostic Scoring Systems for Prediction of Survival in Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S321-S322

2016

Volltextzugriff (PDF)

Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

Journal of viral hepatitis, 2014-02, Vol.21 (2), p.111-120

2014

Volltextzugriff (PDF)

Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?

Acta gastro-enterologica belgica, 2018-10, Vol.81 (4), p.471-475

2018

Volltextzugriff (PDF)

Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

European review for medical and pharmacological sciences, 2016-05, Vol.20 (9), p.1795

2016

Volltextzugriff (PDF)

Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole

European review for medical and pharmacological sciences, 2016-03, Vol.20 (5), p.879

2016

Volltextzugriff (PDF)

P1046 ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

Journal of hepatology, 2014-04, Vol.60 (1), p.S424-S424

2014

Volltextzugriff (PDF)

Infliximab in inflammatory bowel disease: attention to adverse events

European review for medical and pharmacological sciences, 2014-08, Vol.18 (16), p.2337

2014

Volltextzugriff (PDF)

After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey

Journal of clinical gastroenterology, 1999-04, Vol.28 (3), p.241-244

1999

Volltextzugriff (PDF)

520 RESPONSE TO TENOFOVIR TREATMENT OF TREATMENT-NAIVE VS ADEFOVIR-RESISTANT VS SUBOPTIMAL RESPONDER PATIENTS WITH CHRONIC HEPATITIS B

Journal of hepatology, 2012-04, Vol.56, p.S206-S206

2012

Volltextzugriff (PDF)

441 TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2013-04, Vol.58, p.S180-S181

2013

Volltextzugriff (PDF)

Combination Therapy With Hepatitis B Vaccine and Interferon Alfa in Chronic Hepatitis B

The American journal of gastroenterology, 1999-03, Vol.94 (3), p.856-857

1999

Volltextzugriff (PDF)

A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients

Journal of viral hepatitis, 2009-04, Vol.16 (4), p.279-285

2009

Volltextzugriff (PDF)

Estimation of hepatitis C costs in turkey VIA expert opinion: Delphi panel

Value in health, 2014-05, Vol.17 (3), p.A36-A37

2014

Volltextzugriff (PDF)

604 PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

Journal of hepatology, 2010, Vol.52, p.S238-S238

2010

Volltextzugriff (PDF)

Hypogonadism is not related to the etiology of liver cirrhosis

Journal of gastroenterology, 1995-12, Vol.30 (6), p.745-750

1995

Volltextzugriff (PDF)

1 – 25 von 314

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(237)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(163)
Life Sciences & Biomedicine
(159)
Humans
(127)
Female
(102)
Gastroenterology & Hepatology
(99)
Male
(99)
Adult
(96)
Middle Aged
(81)
Aged
(39)
Biological And Medical Sciences
(39)
Adolescent
(38)
Medical Sciences
(38)
Infectious Diseases
(32)
Treatment Outcome
(29)
Gastroenterology And Hepatology
(25)
Antiviral Agents - Therapeutic Use
(22)
Gastroenterology. Liver. Pancreas. Abdomen
(21)
Young Adult
(21)
Retrospective Studies
(20)
Hepatitis B, Chronic - Drug Therapy
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Is belching increasing after bariatric bypass surgery in the long term period?

Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study

Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma

P1182 What has changed in Inflammatory Bowel Disease during last three decades?

P316 Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

P729 Evaluation of hepatobiliary pathologies using transient elastography in patients with inflammatory bowel disease: What about the effect of drugs?

P343 Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period

What is the effect of subepithelial lesions of the esophagus on esophageal motility?

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

Mesoatrial shunt in Budd-Chiari syndrome

Comparison of Prognostic Scoring Systems for Prediction of Survival in Hepatocellular Carcinoma

Treatment failure may lead to accelerated fibrosis progression in patients with chronic hepatitis C

Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?

Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole

P1046 ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

Infliximab in inflammatory bowel disease: attention to adverse events

After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey

520 RESPONSE TO TENOFOVIR TREATMENT OF TREATMENT-NAIVE VS ADEFOVIR-RESISTANT VS SUBOPTIMAL RESPONDER PATIENTS WITH CHRONIC HEPATITIS B

441 TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

Combination Therapy With Hepatitis B Vaccine and Interferon Alfa in Chronic Hepatitis B

A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients

Estimation of hepatitis C costs in turkey VIA expert opinion: Delphi panel

604 PRECORE/CORE PROMOTER MUTATIONS BY ULTRA-DEEP PYROSEQUENCING IN GENOTYPE D CHRONIC HEPATITIS B NAIVE PATIENTS

Hypogonadism is not related to the etiology of liver cirrhosis

Suchergebnisse filtern